Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies

被引：22

作者：

Ahmed, Yousuf ^{[1
]}

Tian, Meijuan ^{[1
]}

Gao, Yong ^{[1
]}

机构：

[1] Univ Western Ontario, Dept Microbiol & Immunol, Schulich Sch Med & Dent, London, ON, Canada

来源：

AIDS RESEARCH AND THERAPY | 2017年 / 14卷

关键词：

HIV-1; Diversity; Broadly neutralizing antibody; Polyvalent vaccine; B cell maturation; HUMAN-IMMUNODEFICIENCY-VIRUS; POTENT NEUTRALIZATION; ENVELOPE GLYCOPROTEIN; RHESUS-MONKEYS; SUBTYPE-B; INFECTION; RESPONSES; PROTECTION; SELECTION; IDENTIFICATION;

D O I：

10.1186/s12981-017-0178-3

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The extreme HIV diversity posts a great challenge on development of an effective anti-HIV vaccine. To solve this problem, it is crucial to discover an appropriate immunogens and strategies that are able to prevent the transmission of the diverse viruses that are circulating in the world. Even though there have been a number of broadly neutralizing anti-HIV antibodies (bNAbs) been discovered in recent years, induction of such antibodies to date has only been observed in HIV-1 infection. Here, in this mini review, we review the progress in development of HIV vaccine in eliciting broad immune response, especially production of bNAbs, discuss possible strategies, such as polyvalent sequential vaccination, that facilitates B cell maturation leading to bNAb response.

引用

页数：6

共 50 条

[21] Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques
Shingai, Masashi
Donau, Olivia K.
Plishka, Ronald J.
Buckler-White, Alicia
Mascola, John R.
Nabel, Gary J.
Nason, Martha C.
Montefiori, David
Moldt, Brian
Poignard, Pascal
Diskin, Ron
Bjorkman, Pamela J.
Eckhaus, Michael A.
Klein, Florian
Mouquet, Hugo
Lorenzi, Julio Cesar Cetrulo
Gazumyan, Anna
Burton, Dennis R.
Nussenzweig, Michel C.
Martin, Malcolm A.
Nishimura, Yoshiaki
JOURNAL OF EXPERIMENTAL MEDICINE, 2014, 211 (10) : 2061 - 2074
[22] Structural Features of Broadly Neutralizing Antibodies and Rational Design of Vaccine
Zhou, Tongqing
Xu, Kai
HIV VACCINES AND CURE: THE PATH TOWARDS FINDING AN EFFECTIVE CURE AND VACCINE, 2018, 1075 : 73 - 95
[23] In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice
Nahmad, Alessio D.
Lazzarotto, Cicera R.
Zelikson, Natalie
Kustin, Talia
Tenuta, Mary
Huang, Deli
Reuveni, Inbal
Nataf, Daniel
Raviv, Yuval
Horovitz-Fried, Miriam
Dotan, Iris
Carmi, Yaron
Rosin-Arbesfeld, Rina
Nemazee, David
Voss, James E.
Stern, Adi
Tsai, Shengdar Q.
Barzel, Adi
NATURE BIOTECHNOLOGY, 2022, 40 (08) : 1241 - +
[24] Broadly Neutralizing Antibodies and the Development of Vaccines
Haynes, Barton F.
Bradley, Todd
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (24): : 2419 - 2420
[25] Phage display as a tool for identifying HIV-1 broadly neutralizing antibodies
Chikaev, A. N.
Rudometov, A. P.
Merkulyeva, Yu A.
Karpenko, L., I
VAVILOVSKII ZHURNAL GENETIKI I SELEKTSII, 2021, 25 (05): : 562 - 572
[26] Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention
Stephenson, Kathryn E.
Wagh, Kshitij
Korber, Bette
Barouch, Dan H.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38, 2020, 38 : 673 - 703
[27] Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies
Rollman, E
Hinkula, J
Arteaga, J
Zuber, B
Kjerrström, A
Liu, M
Wahren, B
Ljungberg, K
GENE THERAPY, 2004, 11 (14) : 1146 - 1154
[28] Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies
E Rollman
J Hinkula
J Arteaga
B Zuber
A Kjerrström
M Liu
B Wahren
K Ljungberg
Gene Therapy, 2004, 11 : 1146 - 1154
[29] Broadly Neutralizing Antibodies for HIV Eradication
Stephenson, Kathryn E.
Barouch, Dan H.
CURRENT HIV/AIDS REPORTS, 2016, 13 (01) : 31 - 37
[30] Broadly Neutralizing Antibodies for HIV Prevention
Karuna, Shelly T.
Corey, Lawrence
ANNUAL REVIEW OF MEDICINE, VOL 71, 2020, 2020, 71 : 329 - 346

← 1 2 3 4 5 →